Search

Your search keyword '"Yoshiki, Okuyama"' showing total 72 results

Search Constraints

Start Over You searched for: Author "Yoshiki, Okuyama" Remove constraint Author: "Yoshiki, Okuyama"
72 results on '"Yoshiki, Okuyama"'

Search Results

1. Clinical outcomes in transplant‐eligible patients with relapsed or refractory diffuse large B‐cell lymphoma after second‐line salvage chemotherapy: A retrospective study

2. Case report: Immune pressure on hematopoietic stem cells can drastically expand glycosylphosphatidylinositol-deficient clones in paroxysmal nocturnal hemoglobinuria

3. Impact of gene alterations on clinical outcome in young adults with myelodysplastic syndromes

4. Mutation profiles of diffuse large B‐cell lymphoma transformation of splenic B‐cell lymphoma/leukemia, unclassifiable on whole‐exome sequencing

5. Case report: Immune pressure on hematopoietic stem cells can drastically expand glycosylphosphatidylinositoldeficient clones in paroxysmal nocturnal hemoglobinuria.

6. SURVEY OF INSTITUTIONAL HANDLING OF REGENERATIVE MEDICAL PRODUCTS CONDUCTED BY THE JAPAN SOCIETY OF TRANSFUSION MEDICINE AND CELL THERAPY IN 2022.

7. Risk factors for <scp>CAR‐T</scp> cell manufacturing failure among <scp>DLBCL</scp> patients: A nationwide survey in Japan

8. Comparison of cryoprotectants in hematopoietic cell infusion–related adverse events

9. NATIONWIDE SURVEY ON HEMATOPOIETIC STEM CELL HARVEST AND OTHER APHERESIS IN JAPAN.

10. Mutation profiles of diffuse large B‐cell lymphoma transformation of splenic B‐cell lymphoma/leukemia, unclassifiable on whole‐exome sequencing

11. [Tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma: real-world data from single institute experience]

12. Hematopoietic cell infusion‐related adverse events in pediatric/small recipients in a prospective/multicenter study

13. Gene rearrangements of MLL and RUNX1 sporadically occur in normal CD34 + cells under cytokine stimulation

14. The Japanese Society for Apheresis clinical practice guideline for therapeutic apheresis

16. Donor-derived gene mutations in sex chromosome loss after stem cell transplantation

17. Prognostic impact of TP53 mutation, monosomal karyotype, and prior myeloid disorder in nonremission acute myeloid leukemia at allo-HSCT

18. SURVEY OF ACTIVITIES OF CERTIFICATED APHERESIS NURSES INVOLVING IN PERIPHERAL BLOOD STEM CELL COLLECTIONS

19. Adverse Events Associated With Infusion of Hematopoietic Stem Cell Products: A Prospective and Multicenter Surveillance Study

20. QUESTIONNAIRE SURVEY ON BLOOD TRANSFUSION IN THE SMALL MEDICAL FACILITIES IN TOKYO METROPOLITAN

21. Chimeric antigen receptor T-cell therapy following autologous transplantation for secondary central nervous system lymphoma

22. Prognostic Impacts of Additional Cytogenetic Abnormalities Acquired at the First Relapse in Adult Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplant in Second Complete Remission

23. Study of twice marrow donations from unrelated donors in Japan Marrow Donor Program

24. THE FIRST NATIONWIDE EXTERNAL QUALITY ASSESSMENT OF CD34+ CELL ENUMERATION IN JAPAN

25. Gene rearrangements of MLL and RUNX1 sporadically occur in normal CD34

26. [Transfusion-associated circulatory overload with pulmonary alveolar hemorrhage following allogeneic bone marrow transplantation]

27. INTER-LABORATORY COMPARISON OF CD34+ CELL ENUMERATION

28. CD25 expression on residual leukemic blasts at the time of allogeneic hematopoietic stem cell transplant predicts relapse in patients with acute myeloid leukemia without complete remission

29. Clinical impact of hematogones on outcomes of allogeneic hematopoietic stem cell transplantation

30. Repeated exposure rather than the total volume of transfused components may influence the incidence of allergic transfusion reactions

31. PROBLEMS OF Rh BLOOD GROUP NOTATION -RESULTS OF A QUESTIONNAIRE SURVEY BY THE KANTO-KOSHINETSU REGIONAL BRANCH OF THE JAPAN SOCIETY OF TRANSFUSION MEDICINE AND CELL THERAPY

32. [Prior harvesting and cryopreservation of peripheral blood stem cells from related donors: current situations in Japan]

33. Clinical and Genetic Characteristics of Adolescent and Young Adult Patients with Myelodysplastic Syndromes

34. Severe Hypoxemia in a Healthy Donor for Allogeneic Hematopoietic Stem Cell Transplantation after Only the First Administration of Granulocyte-Colony Stimulating Factor

35. Presence of TP53 Mutation and Monosomal Karyotype Predict the Outcome of Patients with Acute Myeloid Leukemia in Non-Remission at Allogeneic Stem Cell Transplantation

36. A Prospective, Multicenter Surveillance Study for Adverse Events Associated with Hematopoietic Stem Cell Infusion: Analysis of Pediatric and Low Body-Weight Recipients

37. ANTI-D ANTIBODY PRODUCTION DUE TO TRANSFUSION OF DEL TYPE RBCS TO A D-NEGATIVE RECIPIENT: A CASE REPORT

38. EFFECTIVE USE OF BLOOD PRODUCTS AMONG HOSPITALS

39. Notch Activation Induces the Generation of Functional NK Cells from Human Cord Blood CD34-Positive Cells Devoid of IL-15

40. REVIEW OF ALBUMIN UTILIZATION AT KOMAGOME HOSPITAL IN COMPARISON WITH THAT AT SEVEN GENERAL HOSPITALS

41. Delayed Hematological Recovery Following Autologous Transplantation Utilizing Peripheral Blood Stem Cells Harvested After Treatment with Arsenic Trioxide

42. MEASUREMENT OF PLATELET CONCENTRATES BY A BACTERIAL DETECTION SYSTEM, BDS AND EBDS

43. Low-Dose Antithymocyte Globulin for Treatment of Steroid-Pulse-Resistant Acute Graft-versus-Host Disease

44. HLA antigens in Japanese blood donors with IgA Deficiency

45. Analysis of residual leukocyte subsets in filterd whole blood products

46. Clinical impact of CD25 expression on outcomes of allogeneic hematopoietic stem cell transplant for cytogenetically intermediate-risk acute myeloid leukemia

47. Repeated exposure rather than the total volume of transfused components may influence the incidence of allergic transfusion reactions

48. A retrospective observational study to assess adverse transfusion reactions of patients with and without prior transfusion history

49. Treatment of Relapsing Ph+ Acute Lymphoblastic Leukemia with Donor Leukocyte Infusion Followed by Quantitative Monitoring of Residual Disease

50. A Comparative Study of a New, Fully Automated Procedure and the Standard Mononuclear Cell Program Using the Cobe Spectra for Peripheral Blood Stem Cell Collection

Catalog

Books, media, physical & digital resources